Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive [Phase 4]
This clinical trial update notes the completion of the Phase 4 study LAL-Ph-2000 evaluating treatment for Philadelphia chromosome-positive a…
-
FDA approval · 2009-08-21FDA Approved: TASIGNA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tasigna (nilotinib) submitted by Novartis, resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Glivec in Ph Positive Lymphoblastic Leukemia [Phase 2]
Phase 2 trial update of Glivec (imatinib) in Philadelphia chromosome-positive acute lymphoblastic leukemia; the study status is COMPLETED.
-
FDA approval · 2007-11-08FDA Approved: DASATINIB — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for dasatinib submitted by Prasco Laboratories.
-
CLINICAL_TRIALS research · 2007-10-19Clinical Trial Update: Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) [Phase 2]
This is a Phase 2 clinical trial update comparing imatinib with chemotherapy as induction therapy in elderly patients with Philadelphia chro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. [Phase 2]
Phase 2 trial evaluating Imatinib Mesylate in combination with chemotherapy for elderly patients with Philadelphia chromosome-positive acute…
-
FDA approval · 2006-06-28FDA Approved: DASATINIB — Original Application (Prasco Laboratories)
FDA approved dasatinib under an original application submitted by Prasco Laboratories. The approval covers treatment of Philadelphia chromos…